# Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function

> **NCT00674024** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 8 (actual)

## Conditions studied

- Neoplasms
- Lymphoma

## Interventions

- **DRUG:** Pazopanib
- **DRUG:** Pazopanib (GW786034)(GW786034)

## Key facts

- **NCT ID:** NCT00674024
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10-07
- **Primary completion:** 2013-01-22
- **Final completion:** 2013-01-22
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2019-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00674024

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00674024, "Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00674024. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*